Purpose
To support expansion of manufacturing for the accelerated production of nOPV2 to enable the rapid substitution of nOPV2 for mOPV2 to ensure vaccine supply to at risk infant populations in low income countries.
Grantee
Division
Global Health
Date
FEBRUARY 2024
Region served
GLOBAL
Committed amount
$2,924,450
Grant topic
Vaccine Development
Duration (months)
12
Grantee location
Telangana, India
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.